AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Laser Photonics Corporation

$0.8 -$1.20 (-60.20%)
NASDAQ · 14 Sep 2026 20:00 UTC
Previous Close
$0.69
Day Range
$0.58$0.81
Year Range
$0.38$5.88
Market Cap
37.88M
AVG Volume
10.88M
Trailing/Forward PE
-0.83/-
PEG ratio
0.01
Dividend Yield
-
Next Earnings Date
2026-11-18
Primary Exchange
NASDAQUS
Revenue (USD)
02.5M5M7.5M10M2019202020212022202320242025
LASE Revenue (USD) by year
PeriodRevenue (USD)
20258.34M
20243.42M
20233.94M
20224.95M
20214.19M
20202.15M
20190
Net Income (USD)
-20M-15M-10M-5M05M2019202020212022202320242025
LASE Net Income (USD) by year
PeriodNet Income (USD)
2025-17.46M
2024-3.7M
2023-3.97M
2022-997.46K
2021705.56K
202012.87K
2019-19.55K
Operating Income (USD)
-10M-7.5M-5M-2.5M02.5M2019202020212022202320242025
LASE Operating Income (USD) by year
PeriodOperating Income (USD)
2025-9.15M
2024-7.64M
2023-3.6M
2022-986.72K
2021706.42K
202011.48K
2019-19.55K
EBITDA (USD)
-15M-10M-5M05M2019202020212022202320242025
LASE EBITDA (USD) by year
PeriodEBITDA (USD)
2025-12.7M
2024-5.74M
2023-2.55M
2022-641.57K
20211.23M
202033.09K
201926.92K
Cash Flows (USD)
-10M-5M05M2019202020212022202320242025
LASE Cash Flows (USD) by year
PeriodCash Flows (USD)
2025-6.41M
2024-9.49M
2023-5.96M
2022-827.91K
20211.15M
2020-5.59M
2019-758.26K
EPS (USD)
-1-0.500.52019202020212022202320242025
LASE EPS (USD) by year
PeriodEPS (USD)
2025-0.96
2024-0.35
2023-0.48
2022-0.06
20210.14
20200
2019-0
Expenses (USD)
02.5M5M7.5M10MR&DSG&ACapex2019202020212022202320242025
LASE Expenses (USD) by year
PeriodExpenses (USD)
20259.45M
20247.57M
20235.65M
20223.71M
20211.91M
20205.84M
201919.55K
Cash & Debt (USD)
05M10M15MCashLong Term DebtShort Term Debt2019202020212022202320242025
LASE Cash & Debt (USD) by year
PeriodCash & Debt (USD)
2025650.34K
2024533.87K
20236.2M
202212.18M
2021615.75K
2020326.71K
20190
Debt ratios
-20-100102022202320242025
LASE Debt ratios by year
PeriodDebt ratios
2025-0.38
2024-0.58
20232.91
2022-17.51
Margins
0%20%40%60%80%202020212022202320242025
LASE Margins by year
PeriodMargins
202514.41%
202437.94%
202357.44%
202260.36%
202163.19%
202055.92%
Return on Capital
-100%0%100%200%300%400%2019202020212022202320242025
LASE Return on Capital by year
PeriodReturn on Capital
2025346.58%
2024-36.21%
2023-28.47%
2022-5.82%
202112.69%
20200.24%
2019-3.99%
Shares Outstanding
010M20M30M2019202020212022202320242025
LASE Shares Outstanding by year
PeriodShares Outstanding
202522.85M
202412.67M
20239.02M
20227.88M
20214.88M
20207.88M
20194.88M
Book Value Per Share (USD)
-101232019202020212022202320242025
LASE Book Value Per Share (USD) by year
PeriodBook Value Per Share (USD)
2025-0.22
20240.81
20231.54
20222.17
20211.14
20200.67
20190.1
Total Assets (USD)
05M10M15M20M2019202020212022202320242025
LASE Total Assets (USD) by year
PeriodTotal Assets (USD)
20259.45M
202417.15M
202315.16M
202218.58M
20216.86M
20207.48M
2019495.15K
Employee Count
02550751002022202320242025
LASE Employee Count by year
PeriodEmployee Count
202594
202494
202356
202223
PE Ratio
010203040med 17.07Oct 22Nov 22Dec 22Jan 23Feb 23Mar 23May 23
LASE PE Ratio by year
PeriodPE Ratio
May 2315.63
Apr 2316.25
Apr 2314.5
Apr 2321.15
Apr 2318.67
Mar 2324.09
Mar 2326.1
Mar 2321.72
Mar 2320.74
Mar 2326.52
Feb 2327.24
Feb 2328.32
Feb 2327.96
Feb 2335.59
Jan 2324.76
Jan 2320.94
Jan 2317.59
Jan 2311.71
Dec 2210.52
Dec 2212.43
Dec 229.39
Dec 229.7
Dec 2211.66
Nov 2211.47
Nov 2212.48
Nov 2215.08
Nov 2216.55
Oct 2214.59
Oct 2218.66
Oct 2226.64
Oct 2212.26
Sep 2214
Free Cash Flow Yield
-50%-40%-30%-20%-10%0%med -19.79%Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
LASE Free Cash Flow Yield by year
PeriodFree Cash Flow Yield
Sep 26-28.83%
Sep 26-33.02%
Sep 26-16.39%
Aug 26-15.72%
Aug 26-18.07%
Aug 26-15.51%
Aug 26-23%
Jul 26-26.76%
Jul 26-24.28%
Jul 26-28.33%
Jul 26-19.72%
Jul 26-18.73%
Jun 26-15.34%
Jun 26-11.3%
Jun 26-12.49%
Jun 26-9.05%
May 26-30.53%
May 26-31.25%
May 26-31.86%
May 26-32.14%
May 26-39.07%
Apr 26-28.79%
Apr 26-21.38%
Apr 26-26.16%
Apr 26-23.65%
Mar 26-25.52%
Mar 26-29.63%
Mar 26-22.77%
Mar 26-22.16%
Feb 26-25.17%
Feb 26-32.1%
Feb 26-32.13%
Feb 26-40.91%
Jan 26-12.68%
Jan 26-9.53%
Jan 26-11.44%
Jan 26-11.23%
Jan 26-12.3%
Dec 25-9.28%
Dec 25-22.49%
Dec 25-19.53%
Dec 25-20.72%
Nov 25-17.1%
Nov 25-19.87%
Nov 25-18.89%
Nov 25-17.41%
Oct 25-14.6%
Oct 25-14.6%
Oct 25-14.94%
Oct 25-14.82%
Oct 25-12.73%
Sep 25-12.57%
Sep 25-13.76%
Sep 25-22.32%
Sep 25-28.2%
Aug 25-14.38%
Aug 25-11.4%
Aug 25-22.85%
Aug 25-27.69%
Aug 25-25.21%
Jul 25-22.23%
Jul 25-20.66%
Jul 25-17.41%
Jul 25-27.03%
Jun 25-31.21%
Jun 25-34.61%
Jun 25-30.65%
Jun 25-30.92%
May 25-30.38%
May 25-26.76%
May 25-24.58%
May 25-23.58%
May 25-23.19%
Apr 25-23.27%
Apr 25-25.58%
Apr 25-26.25%
Apr 25-25.58%
Mar 25-22.37%
Mar 25-19.94%
Mar 25-19.22%
Mar 25-18.91%
Feb 25-19.38%
Feb 25-20.17%
Feb 25-17.61%
Feb 25-16.29%
Jan 25-14.68%
Jan 25-13.75%
Jan 25-12.6%
Jan 25-13.46%
Jan 25-11.75%
Dec 24-10.48%
Dec 24-12.65%
Dec 24-12.91%
Dec 24-13.18%
Nov 24-12.45%
Nov 24-10.62%
Nov 24-11.34%
Nov 24-10.12%
Nov 24-11.14%
Oct 24-9.77%
Price to Sales
010203040med 8.2Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
LASE Price to Sales by year
PeriodPrice to Sales
Sep 265.07
Sep 264.43
Sep 268.92
Aug 269.3
Aug 268.09
Aug 269.43
Aug 264.47
Jul 263.85
Jul 264.24
Jul 263.63
Jul 265.22
Jul 265.49
Jun 266.71
Jun 269.11
Jun 268.24
Jun 268.49
May 262.52
May 262.46
May 262.41
May 262.39
May 261.97
Apr 262.67
Apr 262.76
Apr 262.25
Apr 262.49
Mar 262.31
Mar 261.99
Mar 262.59
Mar 262.66
Feb 262.34
Feb 261.84
Feb 261.84
Feb 261.44
Jan 264.65
Jan 266.19
Jan 265.16
Jan 265.25
Jan 264.8
Dec 256.36
Dec 255.29
Dec 256.09
Dec 255.74
Nov 256.95
Nov 255.99
Nov 256.3
Nov 256.83
Oct 258.15
Oct 258.15
Oct 257.96
Oct 258.02
Oct 259.34
Sep 259.47
Sep 258.64
Sep 255.33
Sep 254.22
Aug 258.27
Aug 2510.43
Aug 255.21
Aug 257.02
Aug 257.71
Jul 258.74
Jul 259.4
Jul 2511.16
Jul 257.19
Jun 258.9
Jun 259.88
Jun 2511.16
Jun 2511.06
May 2511.26
May 2512.78
May 2513.91
May 2514.5
May 2514.75
Apr 2514.7
Apr 2513.37
Apr 2513.03
Apr 2513.37
Mar 2515.29
Mar 2517.15
Mar 2517.79
Mar 2518.09
Feb 2517.65
Feb 2516.96
Feb 2519.42
Feb 2520.99
Jan 2523.3
Jan 2524.87
Jan 2527.13
Jan 2525.41
Jan 2529.1
Dec 2432.64
Dec 2427.03
Dec 2426.49
Dec 2425.95
Nov 2427.48
Nov 2432.19
Nov 2417.25
Nov 2419.33
Nov 2417.55
Oct 2420.01
EV/EBITDA
0204060med 15.7Oct 22Dec 22Jan 23Mar 23May 23Jun 23Aug 23
LASE EV/EBITDA by year
PeriodEV/EBITDA
Aug 2322.49
Aug 2327.15
Jul 2327.15
Jul 2327.99
Jul 2330.96
Jul 2334.35
Jun 2338.59
Jun 2336.26
Jun 2338.27
Jun 2355.32
Jun 2343.88
May 2337.32
May 2336.04
May 2334.35
May 2311.35
Apr 2311.79
Apr 2310.55
Apr 2315.25
Apr 2313.5
Mar 2317.33
Mar 2318.75
Mar 2315.65
Mar 2314.96
Mar 2319.04
Feb 2319.55
Feb 2320.31
Feb 2320.06
Feb 2325.45
Jan 2317.8
Jan 2315.1
Jan 2312.73
Jan 238.58
Dec 227.74
Dec 229.09
Dec 226.94
Dec 227.16
Dec 228.54
Nov 228.41
Nov 229.13
Nov 228.89
Nov 229.76
Oct 228.6
Oct 2211.01
Oct 2215.75
Oct 227.22
Sep 228.25
Price/Operating Cashflow
010203040med 13.69Oct 22Nov 22Dec 22Jan 23Feb 23Mar 23May 23
LASE Price/Operating Cashflow by year
PeriodPrice/Operating Cashflow
May 2313.42
Apr 2313.95
Apr 2312.45
Apr 2318.16
Apr 2316.03
Mar 2320.69
Mar 2322.41
Mar 2318.65
Mar 2317.81
Mar 2322.77
Feb 2323.39
Feb 2324.32
Feb 2324.01
Feb 2330.56
Jan 2321.26
Jan 2317.98
Jan 2315.1
Jan 2310.05
Dec 229.04
Dec 2210.67
Dec 228.06
Dec 228.33
Dec 2210.01
Nov 229.85
Nov 2210.72
Nov 228.29
Nov 229.09
Oct 228.02
Oct 2210.25
Oct 2214.63
Oct 226.74
Sep 227.69
Price to Book
05101520med 5.44Jul 24Nov 24Feb 25Jun 25Sep 25Jan 26Apr 26
LASE Price to Book by year
PeriodPrice to Book
Apr 264.8
Apr 263.93
Apr 264.35
Mar 264.03
Mar 263.47
Mar 264.51
Mar 264.64
Feb 264.08
Feb 263.2
Feb 263.2
Feb 262.51
Jan 268.11
Jan 2610.78
Jan 268.98
Jan 269.15
Jan 268.36
Dec 2511.07
Dec 258.46
Dec 259.74
Dec 259.18
Nov 2511.13
Nov 259.58
Nov 2510.07
Nov 2510.93
Oct 2513.04
Oct 2513.04
Oct 2512.74
Oct 2512.84
Oct 2514.94
Sep 2515.14
Sep 2513.83
Sep 258.53
Sep 256.75
Aug 2513.23
Aug 2516.69
Aug 258.33
Aug 255.09
Aug 255.59
Jul 256.34
Jul 256.82
Jul 258.09
Jul 255.21
Jun 252.98
Jun 252.63
Jun 252.97
Jun 252.94
May 253
May 253.4
May 253.7
May 253.86
May 253.92
Apr 253.91
Apr 253.56
Apr 253.47
Apr 253.56
Mar 254.07
Mar 254.56
Mar 254.73
Mar 254.81
Feb 254.7
Feb 254.51
Feb 255.17
Feb 255.59
Jan 256.2
Jan 256.62
Jan 257.22
Jan 256.76
Jan 257.74
Dec 248.68
Dec 247.19
Dec 247.05
Dec 246.91
Nov 247.31
Nov 248.57
Nov 245.2
Nov 245.83
Nov 245.29
Oct 246.03
Oct 246.42
Oct 248.78
Oct 247.27
Sep 2414.77
Sep 2410.72
Sep 245.63
Sep 246.17
Aug 243.52
Aug 242.19
Aug 242.64
Aug 242.51
Aug 241.9
Jul 241.35
Jul 241.48
Jul 241.5
Jul 241.45
Jun 241.49
Jun 241.42
Jun 241.55
Jun 241.51
May 241.57
May 241.54
Laser Photonics Corporation
LASE
Stockpicker

Video analysis: LASE

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: LASE

Laser Photonics Announces Pricing of $7.9 Million Public Offering

accessnewswire.com · 10 Sep 2026

Laser Photonics Announces Pricing of $7.9 Million Public Offering

ORLANDO, FL / ACCESS Newswire / September 10, 2026 / Laser Photonics Corporation (NASDAQ:LASE) (the "Company"), a developer of laser systems for industrial and defense applications, today announced the pricing of a public offering of 10,500,000 shares of common stock, Series B-1 warrants to purchase up to 10,500,000 shares of common stock and Series B-2 warrants to purchase up to 10,500,000 shares of common stock, at a combined public offering price of $0.75 per share and accompanying warrants. The warrants will have an exercise price of $0.75 per share and will be exercisable upon issuance.

Comparing Laser Photonics (NASDAQ:LASE) and Enerpac Tool Group (NYSE:EPAC)

defenseworld.net · 8 Sep 2026

Comparing Laser Photonics (NASDAQ:LASE) and Enerpac Tool Group (NYSE:EPAC)

Enerpac Tool Group (NYSE: EPAC - Get Free Report) and Laser Photonics (NASDAQ: LASE - Get Free Report) are both small-cap industrials companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, dividends, analyst recommendations, risk, profitability, institutional ownership and earnings. Volatility and Risk Enerpac Tool Group

Laser Photonics Receives Repeat Order from Established Canadian Manufacturer for Beamer B-Series Laser Marking System

accessnewswire.com · 3 Sep 2026

Laser Photonics Receives Repeat Order from Established Canadian Manufacturer for Beamer B-Series Laser Marking System

ORLANDO, FL / ACCESS Newswire / September 3, 2026 / Laser Photonics Corporation (NASDAQ:LASE) ("Laser Photonics" or the "Company"), a developer of laser systems for industrial and defense applications, today announced the receipt of a purchase order from an established Canadian manufacturer for a Beamer B-Series FB23 laser marking system and accompanying fume extraction unit. The order was placed by a returning Beamer customer that is upgrading from an earlier-generation Beamer system to the Company's latest-generation marking platform.

LASE Group Advances U.S. Special Operations Command Engagement for Laser Shield Anti-Drone System

accessnewswire.com · 27 Aug 2026

LASE Group Advances U.S. Special Operations Command Engagement for Laser Shield Anti-Drone System

ORLANDO, FL / ACCESS Newswire / August 27, 2026 / Laser Photonics Corporation (NASDAQ: LASE) ("Laser Photonics" or the "Company"), a developer of laser systems for industrial and defense applications, together with Fonon Technologies, an affiliated company within the LASE Group of Companies, today announced continued advancement of its Laser Shield Anti-Drone (LSAD) system following a direct engagement with U.S. Special Operations Command (SOCOM). The engagement provided the LASE Group with an opportunity to present LSAD's directed-energy counter-unmanned aerial system (UAS) capabilities to SOCOM stakeholders and to discuss the platform's potential role in addressing the rapidly expanding threat posed by small unmanned aircraft systems.

Laser Photonics Secures $1.05 Million Order from U.S. Pharmaceutical Manufacturer for High-Speed Tablet Drilling System

accessnewswire.com · 24 Aug 2026

Laser Photonics Secures $1.05 Million Order from U.S. Pharmaceutical Manufacturer for High-Speed Tablet Drilling System

ORLANDO, FL / ACCESS Newswire / August 24, 2026 / Laser Photonics Corporation (NASDAQ:LASE) ("Laser Photonics" or the "Company"), a global leader in laser systems for industrial and defense applications, today announced that its subsidiary, CMS Laser, has received a purchase order valued at approximately $1.05 million from a U.S.-based pharmaceutical company for a TD-70 high-speed pharmaceutical tablet drilling system. The order represents a first-time purchase by this customer and marks the Company's entry into a new pharmaceutical manufacturing account, further extending CMS Laser's precision laser drilling franchise within one of the most quality-intensive and highly regulated end markets it serves.

Franklin Electric (NASDAQ:FELE) vs. Laser Photonics (NASDAQ:LASE) Head-To-Head Survey

defenseworld.net · 17 Aug 2026

Franklin Electric (NASDAQ:FELE) vs. Laser Photonics (NASDAQ:LASE) Head-To-Head Survey

Laser Photonics (NASDAQ: LASE - Get Free Report) and Franklin Electric (NASDAQ: FELE - Get Free Report) are both industrials companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, earnings, dividends, profitability, risk, valuation and analyst recommendations. Earnings and Valuation This table compares Laser Photonics

Laser Photonics Reports Second Quarter 2026 Financial Results

accessnewswire.com · 14 Aug 2026

Laser Photonics Reports Second Quarter 2026 Financial Results

Net Sales Nearly Double Sequentially and Gross Margin Returns to Positive Territory; Laser Shield Anti-Drone System, Developed with Affiliate Fonon Technologies, Advances Through Multiple U.S. Government Evaluation Gates ORLANDO, FL / ACCESS Newswire / August 14, 2026 / Laser Photonics Corporation (NASDAQ:LASE) ("Laser Photonics" or the "Company"), a global leader in laser systems for industrial and defense applications, today reported financial results for the second quarter ended June 30, 2026. $ in thousands Q2 2026 Q2 2025 % Change Total Net Sales $ 1,806 $ 2,599 (30 %) Gross Profit $ 152 $ 1,103 (86 %) Gross Margin % 8.4 % 42.4 % (3,399) b ps Total Operating Expenses $ 2,541 $ 2,065 23 % Net Loss $ (3,278 ) $ (1,774 ) (85 %) Key Second Quarter Fiscal 2026 and Subsequent Operational Highlights: Returned to sequential growth and positive gross margin.

LASE Group's Fonon Technologies Advances Laser Shield Anti-Drone System to Phase 2 U.S. Air Force Evaluation

accessnewswire.com · 23 Jul 2026

LASE Group's Fonon Technologies Advances Laser Shield Anti-Drone System to Phase 2 U.S. Air Force Evaluation

Directed-energy platform selected to demonstrate technical and business viability for rapid point defense and swarm defeat ORLANDO, FL / ACCESS Newswire / July 23, 2026 / Laser Photonics Corporation (NASDAQ:LASE) ("Laser Photonics" or the "Company"), a global leader in laser systems for industrial and defense applications, together with Fonon Technologies, an affiliated company within the LASE Group of Companies, today announced that Fonon Technologies has been selected by the U.S. Air Force (USAF) 20th Contracting Squadron to advance to Phase 2 of the Shaw Air Force Base (AFB) Battle Lab Commercial Solutions Opening (CSO) process. The selection follows a successful evaluation of the Company's solution brief for its Laser Shield Anti-Drone (LSAD) technology under Areas of Interest AOI 2.1 (Rapid Point Defense) and AOI 2.3 (Multi-Threat & Swarm Defeat).

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.